Strategic Merger Potential cross-sell and integration discussions with Sobi following the late-2019 merger activity, indicating openness to expansion through partnerships and alignment with larger specialty pharma players.

Product Launch Dova's Doptelet launch demonstrates experience taking a hematology/oncology adjacent product to market, signaling capability to support commercialization efforts, field teams, and payer strategies for related therapies.

Commercial Leadership Recent appointment of a chief commercial officer suggests emphasis on building a robust commercial organization, a signal for collaboration on market access, sales strategy, and channel development.

Financial Scale Current revenue in the low to mid single digits with a very small employee base indicates high potential for growth-focused engagement, leveraging agile operations and targeted enterprise or specialty collaborations.

Digital Presence Tech stack reliance on WordPress, analytics, and SEO tools implies opportunities to offer digital marketing, website optimization, and data-driven patient or provider engagement solutions to enhance market reach.